Compare WhiteOak Capital Pharma and Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.36
1.86
NAV
₹13.82
₹37.96
Fund Started
16 Jan 2024
25 Jun 2018
Fund Size
₹491.85 Cr
₹6658.41 Cr
Exit Load
Exit load of 1%, if redeemed within 1 months.
Exit load of 1% if redeemed within 15 days.
1 Year
13.37%
8.03%
3 Year
-
27.09%
5 Year
-
16.93%
Equity
98.66%
97.60%
Cash
-0.83%
2.37%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.72% |
JB Chemicals & Pharmaceuticals Ltd. | 9.11% |
Divi's Laboratories Ltd. | 5.48% |
Fortis Healthcare Ltd. | 5.33% |
Lupin Ltd. | 5.16% |
Apollo Hospitals Enterprise Ltd. | 4.90% |
Max Healthcare Institute Ltd. | 4.52% |
Laurus Labs Ltd. | 4.41% |
Alkem Laboratories Ltd. | 3.36% |
Krishna Institute of Medical Sciences Ltd | 2.71% |
Sun Pharmaceutical Industries Ltd. | 11.20% |
Cipla Ltd. | 9.43% |
Dr. Reddy's Laboratories Ltd. | 7.27% |
Mankind Pharma Ltd. | 6.34% |
Divi's Laboratories Ltd. | 6.22% |
Biocon Ltd. | 5.85% |
Lupin Ltd. | 4.80% |
Aurobindo Pharma Ltd. | 3.91% |
Syngene International Ltd. | 2.99% |
Alkem Laboratories Ltd. | 2.90% |
Name
-
-
Start Date
-
-
Description
The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
16 Jan 2024
25 Jun 2018
